Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012

Kevin W. Sharer, chairman and chief executive officer of Amgen AMGN since 2000, has announced his plan to retire from the Company at the end of 2012, following 20 years of service to Amgen.  To facilitate an orderly transition process, Sharer will step down as CEO effective May 23, 2012, and remain as chairman of the Company's Board of Directors until December 31, 2012, at which time he will retire from the Board and from the Company.  Robert Bradway, currently president and chief operating officer, will become CEO on May 23, 2012.  It is the intention of the Board of Directors to elect Bradway chairman of the Board when Sharer retires from that position at the end of 2012.  The Board will also elect a lead independent director at that time.